-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Targeting CD22 and Other Strategies to Overcome CD19 Antigen Escape

Scientific Workshop on Understanding and Overcoming Tumor-intrinsic Resistance to CAR-T Therapies for Lymphoid Malignancies
Program: Scientific Workshops
Session: CAR-19 Resistance in Acute Lymphoblastic Leukemia
Friday, December 6, 2024, 4:18 PM-4:54 PM

Sara Ghorashian, FRCPath, PhD

Haematology, Great Ormond Street Children's Hospital, London, United Kingdom; Developmental Biology and Cancer, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom

Disclosures: Ghorashian: UCLB: Patents & Royalties; Novartis: Honoraria; Autolus PLC: Honoraria, Membership on an entity's Board of Directors or advisory committees.

See more of: CAR-19 Resistance in Acute Lymphoblastic Leukemia
See more of: Scientific Workshop on Understanding and Overcoming Tumor-intrinsic Resistance to CAR-T Therapies for Lymphoid Malignancies
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation